Catalpa Ventures
Venture capitalGrevenmacher · Pre-Seed–Series A · 5 people tracked
Investment thesis
Catalpa Ventures backs early-stage HealthTech founders using technology to address structural challenges in healthcare, including an aging population, a shrinking healthcare workforce, and rising costs. The firm invests from pre-seed to Series A, aiming to be the first institutional investor, with a focus on 'Extended Europe' — DACH, Benelux, and emerging hubs. It views digitalization as central to solving fundamental healthcare problems and considers young innovative companies both economically impactful and drivers of socially sustainable progress. Initial tickets range from €300k to €1.5M, with reserves held for follow-on investments through its Catalpa Health Fund I.
Source: firm website, verified Aug 3, 2026.
Team · 5 people
from the firm's website & public directoriesFrequently asked questions
- What stage does Catalpa Ventures invest at?
- Catalpa Ventures invests at the Pre-Seed, Seed, Series A stages.
- What is Catalpa Ventures's typical check size?
- Catalpa Ventures typically writes checks of $330K – $1.6M.
- What sectors does Catalpa Ventures focus on?
- Catalpa Ventures focuses on Digital Health, Healthtech, Medical Devices.
- Where is Catalpa Ventures located?
- Catalpa Ventures is headquartered in Grevenmacher, LU.
- Does Catalpa Ventures lead rounds?
- Yes, Catalpa Ventures leads investment rounds.
Media · Podcasts & interviews
featuring the teamLuxembourgOfficial - Interview with Thomas Goergen and Silke Sperling (Catalpa Ventures)
360Crossmedia · Thomas Goergen
Images
Similar investors
Foresite Capital is a multi-stage investment firm focused on healthcare and life sciences, backing companies across all stages of growth. It applies a data science-driven approach to invest in businesses leveraging biology and big data to transform healthcare.
Pontifax is an investment firm focused on life sciences and healthcare technologies, backing companies across all development stages from early research to clinical-stage growth.
Cancer Focus Fund is an oncology-focused investment fund established in partnership with The University of Texas MD Anderson Cancer Center to fund and support promising cancer therapies.
Panacea Venture is a global investment firm, spun out from Kleiner Perkins, focused on life sciences and healthcare innovation. It invests across geographies and stages, from company formation through expansion and public markets.
Lang Sheng Investment (朗盛投资) is a leading Chinese investment firm focused on the large healthcare sector, with experience in screening, investing in, and supporting medical and health companies.




